FULC

Fulcrum Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Gould Robert JDirector
$161k15k shares
SellFeb 2, 2026
$10.72
--
Gould Robert JDirector
$178k15k shares
SellJan 2, 2026
$11.87
--
Gould Robert JDirector
$163k15k shares
SellJan 2, 2026
$10.87
--
Oltmans Curtis GaleChief Legal Officer
$45k3.5k shares
SellDec 15, 2025
$12.92
--
Ra Capital Management, L.p.10 Percent Owner
$39M2.7M shares
SellDec 8, 2025
$14.28
--
Ra Capital Management, L.p.10 Percent Owner
$18M1.4M shares
SellDec 8, 2025
$13.33
--

News

prnewswire.comFulcrum Therapeutics, Inc. (FULC) Securities Fraud Investigation - Levi & Korsinskyprnewswire.comJun 9zacks.comFulcrum Therapeutics (FULC) Loses 51% in 4 Weeks, Here's Why a Trend Reversal May be Around the Cornerzacks.comJun 5globenewswire.comLevi & Korsinsky Announces Investigation of Securities Claims Against Fulcrum Therapeutics, Inc. (FULC)globenewswire.comJun 5businesswire.comFULC Investor Alert: Levi & Korsinsky Investigates Fulcrum Therapeutics, Inc. (FULC) for Potential Securities Fraudbusinesswire.comJun 4benzinga.comWhat's Going On With Fulcrum Therapeutics Stock On Thursday?benzinga.comJun 4